| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/1995 | WO1995019384A1 Crosslinked polymeric ammonium salts |
| 07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
| 07/20/1995 | WO1995019363A1 Antiparasitic pyrrolobenzoxazine compounds |
| 07/20/1995 | WO1995019362A1 Dihydro pyrazolopyrroles |
| 07/20/1995 | WO1995019361A1 Process and intermediates for preparing naphthyridonecarboxylic acid salts |
| 07/20/1995 | WO1995019356A1 Endopeptidase 24.15 inhibitor |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | WO1995019338A1 Ligands and metal complexes thereof |
| 07/20/1995 | WO1995019180A1 Anti-gram-positive bacterial methods and materials |
| 07/20/1995 | WO1995019179A1 Anti-fungal methods and materials |
| 07/20/1995 | WO1995019178A1 Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
| 07/20/1995 | WO1995019177A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors |
| 07/20/1995 | WO1995019176A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| 07/20/1995 | WO1995019174A1 Pentoxifylline dosage form |
| 07/20/1995 | WO1995019173A1 Pharmaceutical compositions |
| 07/20/1995 | WO1995019172A1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections |
| 07/20/1995 | WO1995019171A1 Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
| 07/20/1995 | WO1995019170A1 Application of riluzole in the treatment of mitochondrial diseases |
| 07/20/1995 | WO1995019169A2 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor |
| 07/20/1995 | WO1995019168A1 Microgranules of 5-nitro imidazole derivatives |
| 07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | WO1995019166A1 A method for sustained and extended corneal analgesia |
| 07/20/1995 | WO1995019165A1 Method of treating disorders of the eye |
| 07/20/1995 | WO1995019164A1 Use of m3 muscarinic antagonists for the treatment of motion sickness |
| 07/20/1995 | WO1995019162A1 Estradiol penetration intensifier for transdermal administration |
| 07/20/1995 | WO1995019108A1 Method for delipidation of skin and cerumen removal |
| 07/20/1995 | WO1995017165A3 Tissue moisturizing and antimicrobial compositions |
| 07/20/1995 | WO1995016693A3 4'-o-sulfonyl-anthracycline derivatives |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | WO1995006473A3 Medical use of polysulfonic acid compound |
| 07/20/1995 | DE4405591C1 Mittel zur postmenopausalen Hormonsubstitution Means for postmenopausal hormone replacement |
| 07/20/1995 | DE4405590C1 Mittel zur postmenopausalen Hormonbehandlung Means for postmenopausal hormone treatment |
| 07/20/1995 | DE4400843A1 Antitumour and bio-surfactant ester(s) of D,L-alpha-liponic acid |
| 07/20/1995 | DE4400716A1 Compsn. comprising retinol in sodium chloride soln. |
| 07/20/1995 | DE3546830C2 Device for delivering fentanyl across the skin |
| 07/20/1995 | CA2210396A1 Method for detection and treatment of breast cancer |
| 07/20/1995 | CA2192470A1 Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
| 07/20/1995 | CA2181444A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors |
| 07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
| 07/20/1995 | CA2158052A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| 07/20/1995 | CA2156605A1 Ligands and metal complexes thereof |
| 07/20/1995 | CA2140408A1 Production of nucleoside analogues |
| 07/19/1995 | EP0663400A1 Polyisoprene compounds, salts thereof, process for the preparation thereof, and use thereof |
| 07/19/1995 | EP0663398A1 Dihydrate of N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylene diamine hydrochloride (= alfuzosin hydrochloride dihydrate) and a process for the preparation |
| 07/19/1995 | EP0663395A1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole derivatives, process and intermediates for their preparation and their use as cardiac rhythm reduction agent |
| 07/19/1995 | EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors |
| 07/19/1995 | EP0663391A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls |
| 07/19/1995 | EP0663385A2 Salts of pyromellitic acide, a process for their preparation, and their use |
| 07/19/1995 | EP0663210A2 Tumor necrosis factor production inhibitors |
| 07/19/1995 | EP0663209A2 Medicament for inhibiting the effects of amyloidogenic proteins |
| 07/19/1995 | EP0663008A1 Improvements in or relating to immune response modification |
| 07/19/1995 | EP0662977A1 NOVEL 17$g(b)-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME |
| 07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/19/1995 | EP0662975A1 2-substituted adenosines with a-2 receptor affinity. |
| 07/19/1995 | EP0662973A1 Novel cephalosporin derivatives and processes for the preparation thereof |
| 07/19/1995 | EP0662971A1 DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM |
| 07/19/1995 | EP0662970A1 Process for the preparation of 2-amino-6-chloropurine |
| 07/19/1995 | EP0662969A1 Urea and thiourea derivatives and process for their preparation |
| 07/19/1995 | EP0662965A1 1,2-disubstituted ethyl amides as inhibitors of acat |
| 07/19/1995 | EP0662962A1 Substituted pyrimidines for control of diabetic complications |
| 07/19/1995 | EP0662961A1 Process of synthesizing useful intermediates of substituted imidazole compounds |
| 07/19/1995 | EP0662960A1 Unsymmetrically substituted bis-naphthalimides |
| 07/19/1995 | EP0662959A1 5-ht4 antagonists |
| 07/19/1995 | EP0662958A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
| 07/19/1995 | EP0662957A1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
| 07/19/1995 | EP0662950A1 Benzenealkanoic acids for cardiovascular diseases |
| 07/19/1995 | EP0662948A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 07/19/1995 | EP0662946A1 Unsaturated aliphatic dicarboxylic acids |
| 07/19/1995 | EP0662837A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 07/19/1995 | EP0662836A1 Germicidal detergent-iodine compositions having reduced detergent content |
| 07/19/1995 | EP0662835A1 New pharmaceutical formulations of spiramycine. |
| 07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
| 07/19/1995 | EP0662833A1 Aqueous composition |
| 07/19/1995 | EP0662832A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
| 07/19/1995 | EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 07/19/1995 | EP0662830A1 $g(p)-BOND AROMATIC VITAMIN CHELATES |
| 07/19/1995 | EP0662829A1 Polyamine derivatives as anti-cytomegaloviral agents |
| 07/19/1995 | EP0662828A1 Trimethoprim oral liquid |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662822A1 Two-phase matrix for sustained release drug delivery device |
| 07/19/1995 | EP0662821A1 Calcium polycarbophil sprinkle |
| 07/19/1995 | EP0662819A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof. |
| 07/19/1995 | EP0662818A1 Cosmetic composition containing retinol |
| 07/19/1995 | EP0513127B1 Propellant compositions |
| 07/19/1995 | CN1105368A Corticosteroid 17-alkyl carbonate 21-|O¨-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 07/19/1995 | CN1105367A Glucosamine derivative, process for preparing the same and synthetic intermediate thereof |
| 07/19/1995 | CN1105365A Cephalosporin derivatives |
| 07/19/1995 | CN1105363A Quinoline or quinazoline derivatives, their production and use |
| 07/19/1995 | CN1105362A Methods for lowering serum cholesterol |
| 07/19/1995 | CN1105361A Methods for exhibiting angiogenisis and angiogenic diseases |
| 07/19/1995 | CN1105360A 1-|2H-1-benzopyran-2-one-8yl¨-piperazin derivative |
| 07/19/1995 | CN1105359A Methods for inhibiting smooth muscle cell proliferation and restinosis |
| 07/19/1995 | CN1105358A N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 07/19/1995 | CN1105354A Novel alkamine derivative and slat of same |
| 07/19/1995 | CN1105271A Pharmaceutical composition and process |
| 07/19/1995 | CN1105242A Medical use of human early embryo RNA |
| 07/19/1995 | CN1105241A Stable, painless piroxicam potassium injectable composition |
| 07/19/1995 | CN1105240A Pharmaceutical composition |